Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Enthera SrlStartup |
Active Organization Enthera SrlStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Cicatrix | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Cicatrix, Hypertrophic | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Fibrosis | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Immune System Diseases | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Rare Diseases | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Respiratory Diseases | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Skin and Connective Tissue Diseases | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |
Wounds and Injuries | Discovery | - | Enthera SrlStartup | 22 Jun 2023 |